A Phase I trial on fractionated intracavitary radioimmunotherapy and patient-specific dosimetry with Lu-177 labeled 6A10 Fab-fragments in newly diagnosed glioblastoma (RIT in GBM)

Basic data for this project

Type of projectOwn resources project
Duration at the University of Münstersince 01/01/2017

Description

Keywordsglioblastoma

Project management at the University of Münster

Stummer, Walter
Clinic for Neurosurgery

Research associates from the University of Münster

Gerß, Joachim
Institute of Biostatistics and Clinical Research (IBKF)